Yang et al. pointed out that didymin enhanced the expression and activity of Sirtuin 1 (Sirt1), a critical nicotinamide adenine dinucleotide (NAD)-dependent deacetylase, resulting in several beneficial effects to alleviate MASLD. This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatotic liver disease.